Literature DB >> 6906170

Macular holes.

M James, S S Feman.   

Abstract

Twenty-four eyes with macular holes have been followed for periods ranging from one to four years. Each hole was demonstrated, clinically, to be full thickness and associated with a small, localized, retinal detachment and a posterior vitreous separation. With one exception, all eyes were within three diopters of emmetropia, and only one eye developed progression of the retinal detachment. A high incidence of systemic estrogen therapy was noted in these patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6906170     DOI: 10.1007/bf00413397

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  18 in total

1.  Fibrous components of the vitreous body.

Authors:  A GRIGNOLO
Journal:  AMA Arch Ophthalmol       Date:  1952-06

2.  Hole in the macula.

Authors:  L J CROLL; M CROLL
Journal:  Am J Ophthalmol       Date:  1950-02       Impact factor: 5.258

3.  Intimal vascular lesions associated with female reproductive steroids.

Authors:  N S Irey; H J Norris
Journal:  Arch Pathol       Date:  1973-10

4.  The pathology of intracranial venous thrombosis in oral contraception.

Authors:  A A Poltera
Journal:  J Pathol       Date:  1972-04       Impact factor: 7.996

5.  The role of estradiol withdrawal in the etiology of menstrual migraine.

Authors:  B W Somerville
Journal:  Neurology       Date:  1972-04       Impact factor: 9.910

6.  Arteriole alteration in normal and hyperplastic endometrium.

Authors:  C A Salvatore
Journal:  Am J Obstet Gynecol       Date:  1968-10-15       Impact factor: 8.661

7.  [Treatment of retinal detachment with macular hole].

Authors:  M Mikuni; S Kobayashi; H Yaoeda
Journal:  Nihon Ganka Kiyo       Date:  1967-06

8.  [Clinical studies on the macular hole. 3. On the pathogenesis of the senile macular hole].

Authors:  H Yoshioka
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1968-05-10

9.  Central retinal vascular occlusion associated with oral contraceptives.

Authors:  G C Stowe; Z N Zakov; D M Albert
Journal:  Am J Ophthalmol       Date:  1978-12       Impact factor: 5.258

10.  [Macular hole and cyst: a report of eight cases].

Authors:  N Mori; E Yusa
Journal:  Nihon Ganka Kiyo       Date:  1966-05
View more
  8 in total

Review 1.  Idiopathic full thickness macular hole: natural history and pathogenesis.

Authors:  E Ezra
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

2.  Are biometric parameters a risk factor for idiopathic macular hole formation? Results of a matched case-control series.

Authors:  S P Shah; C Bunce; R L Johnston; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

3.  Vitreomacular observations. II. Data on the pathogenesis of idiopathic macular breaks.

Authors:  A Kakehashi; C L Schepens; C L Trempe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-07       Impact factor: 3.117

4.  Bilaterality of idiopathic macular holes.

Authors:  M L Lewis; S M Cohen; W E Smiddy; J D Gass
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

5.  Senile idiopathic macular holes.

Authors:  J A Kruis; L A Bastiaensen; K L Hoefnagels
Journal:  Doc Ophthalmol       Date:  1983-02-28       Impact factor: 2.379

6.  Vitreous estrogen levels in patients with an idiopathic macular hole.

Authors:  Naoki Inokuchi; Tsunehiko Ikeda; Kimitoshi Nakamura; Seita Morishita; Masanori Fukumoto; Teruyo Kida; Hidehiro Oku
Journal:  Clin Ophthalmol       Date:  2015-03-20

7.  Optical coherence tomography angiography features in patients with idiopathic full-thickness macular hole, before and after surgical treatment.

Authors:  Tomasz Wilczyński; Anna Heinke; Agata Niedzielska-Krycia; Daria Jorg; Katarzyna Michalska-Małecka
Journal:  Clin Interv Aging       Date:  2019-03-08       Impact factor: 4.458

Review 8.  Gonadal Hormones and Retinal Disorders: A Review.

Authors:  Raffaele Nuzzi; Simona Scalabrin; Alice Becco; Giancarlo Panzica
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-02       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.